Duggingerstrasse 23
Reinach 4153
Switzerland
41 61 485 2000
https://www.evolva.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Gerhard Lobmaier | Chief Operations Officer | N/A | N/A | 1969 |
Thomas Schneckenburger C.F.A., Ph.D. | Head of Investor & Corporate Relations | N/A | N/A | N/A |
Philipp Frech | General Counsel & Secretary of the Board | N/A | N/A | N/A |
Ms. Anne De Vos | Head of Sales | N/A | N/A | 1964 |
Ms. Astrid Schafer | Head of Innovation | N/A | N/A | 1973 |
Dr. Luc Gruner | Executive Officer | N/A | N/A | 1952 |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature made ingredient via fermentation that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
Evolva Holding SA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.